Genmab — December 2012
-
det er ikke imponerende mængder der bliver handlet
-
82
-
eller 81,36-81,95
-
ja hvis carnegie skal have noget så går det op
-
de kan fortsat ikke få særligt mange, så hvis de skal sætte tryk på volumen så skal de altså pænt op i kurs
-
hvis Carnegie skal have flere sp kommer det til at gå op
-
@gen.co men volumen er lav, så de skal nok ikke have for mange
-
men det er lidt kedeligt at sidde og vente på at carnegie nu skal fedtspille hele dagen
-
det ser ud som om Nordea også blev træt af at vente
-
ritux laver den subkutane....http://medwatch.dk/secure/Medicinal___Biotek/article4941863.ece?1355137858330
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind